These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3096503)

  • 1. [Biochemical characterization of an immune serum which specifically marks neurons in neurofibrillary degeneration in Alzheimer's disease].
    Delacourte A; Défossez A
    C R Acad Sci III; 1986; 303(11):439-44. PubMed ID: 3096503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.
    Bondareff W; Wischik CM; Novak M; Amos WB; Klug A; Roth M
    Am J Pathol; 1990 Sep; 137(3):711-23. PubMed ID: 2169192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease].
    Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA
    Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocytochemical study at the ultrastructural level of neurofibrillary degeneration in Alzheimer's disease].
    Defossez A; el Hachimi K; Beauvillain JC; Perre J; Delacourte A; Foncin JF
    C R Acad Sci III; 1987; 304(9):217-22. PubMed ID: 3102001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer neurofibrillary tangles: antiserum and immunohistological staining.
    Grundke-Iqbal I; Johnson AB; Terry RD; Wisniewski HM; Iqbal K
    Ann Neurol; 1979 Dec; 6(6):532-7. PubMed ID: 394670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
    Goedert M; Jakes R; Spillantini MG; Hasegawa M; Smith MJ; Crowther RA
    Nature; 1996 Oct; 383(6600):550-3. PubMed ID: 8849730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments.
    Delacourte A; Defossez A
    J Neurol Sci; 1986 Dec; 76(2-3):173-86. PubMed ID: 3098926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders.
    Buée-Scherrer V; Buée L; Leveugle B; Perl DP; Vermersch P; Hof PR; Delacourte A
    Ann Neurol; 1997 Sep; 42(3):356-9. PubMed ID: 9307257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
    Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
    FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
    Dessi F; Colle MA; Hauw JJ; Duyckaerts C
    Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.
    Brion JP; Couck AM; Passareiro E; Flament-Durand J
    J Submicrosc Cytol; 1985 Jan; 17(1):89-96. PubMed ID: 3973960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions.
    Gambetti P; Autilio-Gambetti L; Perry G; Shecket G; Crane RC
    Lab Invest; 1983 Oct; 49(4):430-5. PubMed ID: 6620982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration.
    Dickson DW; Ksiezak-Reding H; Davies P; Yen SH
    Acta Neuropathol; 1987; 73(3):254-8. PubMed ID: 2441560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation.
    Su JH; Deng G; Cotman CW
    Neurobiol Dis; 1997; 4(5):365-75. PubMed ID: 9440125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
    Perl DP; Good PF
    J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.